Louisiana Republican Rep. Charles Boustany Jr. says physician groups suggest the OTC prescription requirement imposes an unreasonable administrative burden, causes longer waits for appointments and increases health care costs.
A House Ways and Means subcommittee chairman will ask how a requirement to obtain prescriptions to purchase OTCs with pre-tax savings accounts is adversely affecting consumers.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
The HHS Secretary publicly acknowledged the unusual delay of Novavax's COVID-19 vaccine licensure, but his justification was neither scientifically accurate nor legally justifiable, experts said.
Jonathan Blum, who was principal deputy administrator during the Biden Administration, explained the agency’s approach to setting up the price negotiation program and said changes likely will be implemented by the Trump Administration.
The hub’s goals of efficiency, centralization and coordination fit with the Trump Administration’s current focus for the FDA, Amy Comstock Rick, director of strategic coalitions, told the Biopharma Congress.
